摘要
许多因素都可以影响骨代谢,雌激素与绝经后骨质疏松症的关系更为重要。目前性激素替代疗法(HRT)仍是绝经后骨质疏松症的主要治疗方法,但应全面、深刻地认识HRT的受益与风险。
Many factors can impact bone metabolism,the relationship between estrin and postmenopausal is more important.At present, HRT is also the main treatment of postmenopausal,but we should fully understand the advantages and also the crisis of HRT.
出处
《中国药业》
CAS
2005年第5期18-20,共3页
China Pharmaceuticals
关键词
绝经后骨质疏松症
性激素替代疗法
风险
postmenopausal osteoporosis
hormones replacement treatment(HRT)
crisis
